Stop TB Partnership

GDF Facts & Figures

142 countries have procured $2.15 billion in TB medicines and diagnostics from GDF since its inception in 2001:

First-Line Medicines (since 2001)
  • Cumulative value of first-line medicines procured: $856,863,535
  • Cumulative number of adult, first-line medicine treatments delivered: 31,575,684
  • Cumulative number of paediatric, first-line medicine treatments delivered: 2,378,404
  • Number of countries that have procured first-line medicines via GDF: 124
Second-Line Medicines (since 2007)
  • Cumulative value of second-line medicines procured: $1,004,687,252
  • Cumulative number of second-line medicine treatments delivered: 358,697
  • Number of countries that have procured second-line medicines via GDF: 127
Diagnostics (since 2008)
  • Cumulative value of diagnostics procured: $294,309,550
  • Number of countries that have procured diagnostics via GDF: 104

Last updated: May 2019

Please email us at gdf@stoptb.org for the most recent facts and figures.

ISO

GDF is ISO 9001:2015 compliant for the provision of quality assured anti-TB drugs and related services to eligible national TB control programmes.